|
| Overall Recruitment Status: Active, currently enrolling |
| |
| Official Title |
| NCI COVID-19 in Cancer Patients Study (N-CCaPS): A Longitudinal Natural History Study |
| |
| Region |
Sponsors |
| Mid-Atlantic |
|
| |
| Acronym |
KP IRB No. |
| N-CCaPS |
1625765 |
| |
| Study Type |
Phase |
| Prospective Cohort Study with Direct Patient Contact |
|
| |
| Study Population Description |
|
| |
| Purpose |
| This study collects blood samples, medical information, and medical images from patients who are being treated for cancer and have a positive test for SARS CoV-2, the new coronavirus that causes the disease called COVID-19. Collecting blood samples, medical information, and medical images may help researchers determine how COVID-19 affects the outcomes of patients undergoing cancer treatment and how having cancer affects COVID-19. |
| |
| Detailed Description |
|
| |
| Gender |
Age Limit |
| Male & Female |
|
| |
- Prior or current cancer diagnosis (e.g., solid tumor or hematologic malignancy) and is currently receiving active treatment, received an allogenic stem cell transplant or chimeric antigen receptor (CAR)-T cell or other modified cellular therapy at any time, is currently receiving treatment or prophylaxis for graft versus (vs.) host disease, or has received an autologous bone marrow transplant within the past 2 years.
|
-
Pending or known positive viral test result for SARS-CoV-2.
|
- For patients 18 years of age or older, the specimen collection for the positive test must have occurred no earlier than 14 days prior to enrollment.
|
|
| |
-
Metastatic Malignant Solid Neoplasm
|
|
|
|
|
- Hematopoietic and Lymphoid Cell Neoplasm
|
|
|
| |
|